![(2S)-1-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3,3-dimethyl-2-[(pyridin-4-ylmethyl)amino]butan-1-one](https://static.cymitquimica.com/cas-image/398488-2s-1-67-dimethoxy-34-dihydroisoquinolin-2-1h-yl-33-dimethyl-2-pyridin-4-ylmethyl-amino-butan-1-one.png)
CAS: 372523-75-6 - (2S)-1-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3,3-dimethyl-2-[(pyridin-4-ylmethyl)amino]butan-1-one
Formula:C23H31N3O3
InChI:InChI=1S/C23H31N3O3/c1-23(2,3)21(25-14-16-6-9-24-10-7-16)22(27)26-11-8-17-12-19(28-4)20(29-5)13-18(17)15-26/h6-7,9-10,12-13,21,25H,8,11,14-15H2,1-5H3/t21-/m1/s1
InChI key:InChIKey=COFVZFLCAOUMJT-OAQYLSRUSA-N
SMILES:O=C(N1CC2=CC(OC)=C(OC)C=C2CC1)C(NCC=3C=CN=CC3)C(C)(C)C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TCS OX2 29 REF: AN-AG007A5QCAS: 372523-75-6 | 95% | 67.00 €~588.00 € | Mon 06 May 24 |
 | TCS-OX2-29 REF: TM-T4965CAS: 372523-75-6 | 99.08% | 46.00 €~462.00 € | Mon 13 May 24 |
 | TCS-OX2-29 REF: 3D-XPA52375CAS: 372523-75-6 | Min. 95% | To inquire | Mon 17 Jun 24 |
Ref: AN-AG007A5Q
| 1g | 588.00 € | |
| 10mg | 67.00 € | |
| 50mg | 140.00 € | |
| 100mg | 170.00 € | |
| 250mg | 251.00 € |
Estimated delivery in United States, on Monday 6 May 2024
TCS-OX2-29
CAS:372523-75-6
TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold …
Formula:
C23H31N3O3
Purity:
99.08%
Color and Shape:
Solid
Molecular weight:
397.51
Ref: TM-T4965
| 2mg | 46.00 € | |
| 5mg | 69.00 € | |
| 10mg | 94.00 € | |
| 25mg | 176.00 € | |
| 50mg | 258.00 € | |
| 100mg | 462.00 € | |
| 1ml*10 (DMSO) | 75.00 € |
Estimated delivery in United States, on Monday 13 May 2024
TCS-OX2-29
CAS:372523-75-6
TCS-OX2-29 is a novel nicotinic acetylcholine receptor (nAChR) ligand that binds to the ventral and …
Formula:
C23H31N3O3
Purity:
Min. 95%
Molecular weight:
397.51 g/mol
Ref: 3D-XPA52375
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024
